news report
FDA Picks Dexcom for First TEMPO Digital Health Pilot
The glucose program will generate real-world evidence inside Medicare’s ACCESS model as FDA plans up to about 10 participants in each of four clinical-use areas.
topics
Continuous glucose monitoring